Research and Markets: Chemical Industry Market Report 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sfvtgv/chemical_industry) has announced the addition of the "Chemical Industry Market Report 2013" report to their offering.

This Key Note Market Report Update analyses the UK chemical industry, which is essentially concerned with the production and consumption of organic and inorganic substances. The UK chemical industry is one of the country's largest manufacturing sectors and also one of the largest sources of exports for the manufacturing markets.

The chemical industry, like virtually every other industry in the UK, has been significantly impacted by the recent economic downturn. In 2009, UK manufacturers' total sales of chemicals, chemical products and man-made fibres fell by 12.4%. The market did, however, bounce back in the following years and recorded a rise of 9.5% and 5.7% in 2010 and 2011, respectively.

Basic chemicals is the UK chemical industry's largest sector, accounting for 39.5% of manufacturers' sales in 2011, followed by the basic pharmaceutical products and pharmaceutical preparations sector, which accounted for 30.2% of total sales of chemicals in the same year.

In 2012, the European Chemical Industry Council (CEFIC) conducted a survey that was carried out in ten European countries. It asked for opinions on the chemicals industry in 16 discrete areas including safe use, the environment, plant safety, competitiveness, economic impact and waste disposal. The survey found that the UK chemical industry has a more positive reputation than any other EU country in the survey. Meanwhile, high energy costs in the UK remain a major issue for chemical manufacturers. According to a survey by the Chemical Industries Association (CIA), the cost of energy was the top concern of British chemical and pharmaceutical companies, ahead of the regulatory climate and employers' additional social costs.

Key Note forecasts that the UK chemical industry will grow by an estimated 16.3% between 2012 and 2016. Companies that are focused on export markets, particularly those in strong emerging economies, are likely to fare best over the forecast period. The ageing of the UK's population is expected to drive long-term demand in the pharmaceuticals sector, while new product innovation will remain one of the key drivers for growth in the market in future years.

Companies Mentioned

- Astrazeneca Plc

- BP Chemicals Ltd

- Cookson Group Plc

- Croda International Plc

- Glaxosmithkline Plc

- Ineos Group Holdings Ltd

- Johnson Matthey Plc

- Shell Chemicals Uk Ltd

- Yule Catto And Co Plc

For more information visit http://www.researchandmarkets.com/research/sfvtgv/chemical_industry